CURE vs VTI
Direxion Daily Healthcare Bull 3X ETF vs Vanguard Total Stock Market ETF
Quick Verdict
VTI has a lower expense ratio. CURE delivered stronger 1-year returns. VTI offers more diversification with 2783 holdings.
Side-by-Side Comparison
| Metric | CURE | VTI | Winner |
|---|---|---|---|
| Expense Ratio | 0.94% | 0.03% | |
| AUM | $181M | $663.5B | |
| Dividend Yield | 1.12% | 1.07% | |
| Holdings | 67 | 3,543 | |
| YTD Return | +16.83% | +14.22% | |
| 1Y Return | +87.65% | +22.19% | |
| 3Y Return (annualized) | +8.79% | +21.27% | |
| 5Y Return (annualized) | +2.56% | +12.23% | |
| Volatility (annualized) | 41.9% | 15.3% | |
| Max Drawdown | -69.2% | -56.6% | |
| Fund Family | Direxion Shares ETF Trust | Vanguard (US) | |
| Category | Alternative | Equity | |
| Inception | Jun 15, 2011 | May 24, 2001 |
CURE vs VTI Performance
Direxion Daily Healthcare Bull 3X ETF (CURE) is a ETF from Direxion Shares ETF Trust and Vanguard Total Stock Market ETF (VTI) is a ETF from Vanguard (US). Over the past year CURE returned +87.65% while VTI returned +22.19%. Year to date, CURE is up 16.83% versus a gain of 14.22% for VTI.
Over three years, CURE compounded at +8.79% per year against +21.27% for VTI; over five years the annualized figures are +2.56% and +12.23% respectively. Across the full 15-year window we track, CURE has the edge at +24.53% annualized vs +8.14%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CURE has been the more volatile fund, with annualized monthly volatility of 41.9% compared with 15.3% for VTI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -69.2% for CURE and -56.6% for VTI. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.73. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CURE charges 0.94% per year while VTI charges 0.03%. On a $10,000 position that is $94 vs $3 annually, a gap of $91 per year that compounds over a long holding period. On income, CURE currently yields 1.12% against 1.07% for VTI.
Holdings Overlap
CURE and VTI share 55 holdings out of 2790 unique holdings combined, representing a 7.8% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, CURE or VTI?
CURE has an expense ratio of 0.94% while VTI charges 0.03%. VTI is the cheaper option. On a $10,000 investment, that is $91 per year of difference.
Which performed better, CURE or VTI?
Over the past year CURE returned +87.65% vs +22.19% for VTI, so CURE leads on 1-year performance. Over the longest common window we track (15 years), CURE annualized +24.53% vs +8.14% for VTI. Past performance does not guarantee future results.
Which is riskier, CURE or VTI?
CURE has been the more volatile fund at 41.9% annualized versus 15.3% for VTI. Worst drawdown: CURE -69.2% vs VTI -56.6%.
Should I hold both CURE and VTI?
CURE and VTI have a monthly-return correlation of 0.73, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between CURE and VTI?
CURE and VTI share 55 common holdings with a 7.8% weight overlap. Combined, they hold 2790 unique securities.
Which pays a higher dividend, CURE or VTI?
CURE yields 1.12% while VTI yields 1.07%, so CURE currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.